Location and dynamics of the immunodominant CD8 T cell response to SIVΔnef immunization and SIVmac251 vaginal challenge

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Sasikala Appukuttan, Arun K ^a   Kim, Hyeon O ^a   Kinzel, Nikilyn J ^a   Hong, Jung Joo ^a   Smith, Anthony J ^a,e   Wagstaff, Reece ^a   Reilly, Cavan ^b   Piatak Jr , Michael ^c   Lifson, Jeffrey D ^c   Reeves, R Keith ^d   Johnson, R Paul ^d   Haase, Ashley T ^a   Skinner, Pamela J ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e DeVry Medical International   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SIMIAN IMMUNODEFICIENCY VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CELL AGGREGATION; CELL DENSITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; INFECTION PREVENTION; LAMINA PROPRIA; LYMPHOID TISSUE; NONHUMAN; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; UTERINE CERVIX; VACCINATION; VAGINA; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS STRAIN; WILD TYPE;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; FEMALE; GENE DELETION; GENE EXPRESSION; HUMANS; IMMUNITY, ACTIVE; MACACA MULATTA; MUCOUS MEMBRANE; SAIDS VACCINES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINATION; VACCINES, ATTENUATED; VAGINA; VIRAL LOAD; VIRAL REGULATORY AND ACCESSORY PROTEINS;

EID: 84892593683     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081623     Document Type: Article

References (34)

1. UNAIDS. (2012) Global report: UNAIDS report on the global AIDS epidemic 2012.
2. Quinn TC, Overbaugh J. (2005) HIV/AIDS in women: An expanding epidemic. Science 308: 1582-1583. 10.1126/science.1112489.
3. Fauci AS, Johnston MI, Dieffenbach CW, Burton DR, Hammer SM, et al. (2008) HIV vaccine research: The way forward. Science 321: 530-532. 10.1126/science.1161000.
4. Corey L, Nabel GJ, Dieffenbach C, Gilbert P, Haynes BF, et al. (2011) HIV-1 vaccines and adaptive trial designs. Sci Transl Med 3: 79ps13. 10.1126/scitranslmed.3001863.
5. Koff WC, Johnson PR, Watkins DI, Burton DR, Lifson JD, et al. (2006) HIV vaccine design: Insights from live attenuated SIV vaccines. Nat Immunol 7: 19-23.
6. Hansen SG, Jr MP, Ventura AB, Hughes CM, Gilbride RM, et al. (2013) Immune clearance of highly pathogenic SIV infection. Nature. 10.1038/nature12519.
7. Hansen SG, Ford JC, Lewis MS, Ventura AB, Hughes CM, et al. (2011) Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine. Nature 473: 523-527. 10.1038/nature10003.
8. Bilello JP, Manrique JM, Shin YC, Lauer W, Li W, et al. (2011) Vaccine protection against simian immunodeficiency virus in monkeys using recombinant gamma-2 herpesvirus. J Virol 85: 12708-12720. 10.1128/JVI.00865-11.
9. Daniel MD, Kirchhoff F, Czajak SC, Sehgal PK, Desrosiers RC. (1992) Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258: 1938-1941.
10. Johnson RP, Lifson JD, Czajak SC, Cole KS, Manson KH, et al. (1999) Highly attenuated vaccine strains of simian immunodeficiency virus protect against vaginal challenge: Inverse relationship of degree of protection with level of attenuation. J Virol 73: 4952-4961.
11. Reynolds MR, Weiler AM, Weisgrau KL, Piaskowski SM, Furlott JR, et al. (2008) Macaques vaccinated with live-attenuated SIV control replication of heterologous virus. J Exp Med 205: 2537-2550.
12. Connor RI, Montefiori DC, Binley JM, Moore JP, Bonhoeffer S, et al. (1998) Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine. J Virol 72: 7501-7509.
13. Johnson RP. (1999) Live attenuated AIDS vaccines: Hazards and hopes. Nat Med 5: 154-155. 10.1038/5515.
14. Tenner-Racz K, Stahl Hennig C, Uberla K, Stoiber H, Ignatius R, et al. (2004) Early protection against pathogenic virus infection at a mucosal challenge site after vaccination with attenuated simian immunodeficiency virus. Proc Natl Acad Sci U S A 101: 3017-3022. 10.1073/pnas.0308677101.
15. Wyand MS, Manson K, Montefiori DC, Lifson JD, Johnson RP, et al. (1999) Protection by live, attenuated simian immunodeficiency virus against heterologous challenge. J Virol 73: 8356-8363.
16. Reynolds MR, Weiler AM, Piaskowski SM, Kolar HL, Hessell AJ, et al. (2010) Macaques vaccinated with simian immunodeficiency virus SIVmac239Delta nef delay acquisition and control replication after repeated low-dose heterologous SIV challenge. J Virol 84: 9190-9199. 10.1128/JVI.00041-10.
17. Mudd PA, Martins MA, Ericsen AJ, Tully DC, Power KA, et al. (2012) Vaccine-induced CD8+ T cells control AIDS virus replication. Nature 491: 129-133. 10.1038/nature11443.
18. Manrique M, Kozlowski PA, Cobo-Molinos A, Wang SW, Wilson RL, et al. (2011) Long-term control of simian immunodeficiency virus mac251 viremia to undetectable levels in half of infected female rhesus macaques nasally vaccinated with simian immunodeficiency virus DNA/recombinant modified vaccinia virus ankara. J Immunol 186: 3581-3593. 10.4049/jimmunol.1002594.
19. Barouch DH, Liu J, Li H, Maxfield LF, Abbink P, et al. (2012) Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys. Nature 482: 89-93. 10.1038/nature10766.
20. Patel V, Jalah R, Kulkarni V, Valentin A, Rosati M, et al. (2013) DNA and virus particle vaccination protects against acquisition and confers control of viremia upon heterologous simian immunodeficiency virus challenge. Proc Natl Acad Sci U S A 110: 2975-2980. 10.1073/pnas.1215393110.
21. Liu J, O'Brien KL, Lynch DM, Simmons NL, La Porte A, et al. (2009) Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys. Nature 457: 87-91. 10.1038/nature07469.
22. Reynolds MR, Rakasz E, Skinner PJ, White C, Abel K, et al. (2005) CD8+ T-lymphocyte response to major immunodominant epitopes after vaginal exposure to simian immunodeficiency virus: Too late and too little. J Virol 79: 9228-9235.
23. Miller CJ, Li Q, Abel K, Kim EY, Ma ZM, et al. (2005) Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. J Virol 79: 9217-9227.
24. Li Q, Skinner PJ, Ha SJ, Duan L, Mattila TL, et al. (2009) Visualizing antigen-specific and infected cells in situ predicts outcomes in early viral infection. Science 323: 1726-1729.
25. Johnson RP, Desrosiers RC. (1998) Protective immunity induced by live attenuated simian immunodeficiency virus. Curr Opin Immunol 10: 436-443.
26. de Groot NG, Otting N, Robinson J, Blancher A, Lafont BA, et al. (2012) Nomenclature report on the major histocompatibility complex genes and alleles of great ape, old and new world monkey species. Immunogenetics 64: 615-631. 10.1007/s00251-012-0617-1.
27. Mothe BR, Horton H, Carter DK, Allen TM, Liebl ME, et al. (2002) Dominance of CD8 responses specific for epitopes bound by a single major histocompatibility complex class I molecule during the acute phase of viral infection. J Virol 76: 875-884.
28. Skinner PJ, Daniels MA, Schmidt CS, Jameson SC, Haase AT. (2000) Cutting edge: In situ tetramer staining of antigen-specific T cells in tissues. J Immunol 165: 613-617.
29. Skinner PJ, Haase AT. (2005) In situ staining using MHC class I tetramers. Curr Protoc Immunol Chapter 17: Unit 17.4.
30. Salisch NC, Kaufmann DE, Awad AS, Reeves RK, Tighe DP, et al. (2010) Inhibitory TCR coreceptor PD-1 is a sensitive indicator of low-level replication of SIV and HIV-1. J Immunol 184: 476-487. 10.4049/jimmunol.0902781.
31. Hong JJ, Reynolds MR, Mattila TL, Hage A, Watkins DI, et al. (2009) Localized populations of CD8 MHC class I tetramer SIV-specific T cells in lymphoid follicles and genital epithelium. PLoS One 4: e4131. 10.1371/journal.-pone.0004131; 10.1371/journal.pone.0004131.
32. Miller CJ, McChesney M, Moore PF. (1992) Langerhans cells, macrophages and lymphocyte subsets in the cervix and vagina of rhesus macaques. Lab Invest 67: 628-634.
33. Johansson EL, Rudin A, Wassen L, Holmgren J. (1999) Distribution of lymphocytes and adhesion molecules in human cervix and vagina. Immunology 96: 272-277.
34. Genesca M, Skinner PJ, Bost KM, Lu D, Wang Y, et al. (2008) Protective attenuated lentivirus immunization induces SIV-specific T cells in the genital tract of rhesus monkeys. Mucosal Immunol 1: 219-228.